Soluble CD163 as a Potential Biomarker in Systemic Sclerosis
Sign Up to like & getrecommendations! Published in 2018 at "Disease Markers"
DOI: 10.1155/2018/8509583
Abstract: Objective To evaluate the performance of serum and urinary sCD163 concentrations as possible biomarker in systemic sclerosis (SSc). Methods Urine and serum samples were obtained from SSc patients and age- and sex-matched controls. Serum and… read more here.
Keywords: biomarker systemic; ssc patients; scd163; urinary scd163 ... See more keywords
Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0282153
Abstract: There is ample epidemiological and animal-model evidence suggesting that intestinal inflammation is associated with the development of Parkinson’s disease (PD). Leucine-rich α2 glycoprotein (LRG) is a serum inflammatory biomarker used to monitor the activity of… read more here.
Keywords: lrg levels; serum; serum lrg; biomarker systemic ... See more keywords
Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2025.1689327
Abstract: Objective Choroidal thickness (CT) varies with systemic inflammatory activity in diseases such as spondyloarthritis, suggesting its potential role as a biomarker. This study aimed to evaluate changes in CT in patients recently diagnosed with Polymyalgia… read more here.
Keywords: biomarker systemic; pmr; thickness; polymyalgia rheumatica ... See more keywords